319 related articles for article (PubMed ID: 20526205)
1. Japanese ethnicity compared with Caucasian ethnicity and never-smoking status are independent favorable prognostic factors for overall survival in non-small cell lung cancer: a collaborative epidemiologic study of the National Hospital Organization Study Group for Lung Cancer (NHSGLC) in Japan and a Southern California Regional Cancer Registry databases.
Kawaguchi T; Matsumura A; Fukai S; Tamura A; Saito R; Zell JA; Maruyama Y; Ziogas A; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 Jul; 5(7):1001-10. PubMed ID: 20526205
[TBL] [Abstract][Full Text] [Related]
2. Korean ethnicity as compared with white ethnicity is an independent favorable prognostic factor for overall survival in non-small cell lung cancer before and after the oral epidermal growth factor receptor tyrosine kinase inhibitor era.
Ahn MJ; Lee J; Park YH; Ahn JS; Ziogas A; Zell JA; Park K; Ou SH
J Thorac Oncol; 2010 Aug; 5(8):1185-96. PubMed ID: 20592628
[TBL] [Abstract][Full Text] [Related]
3. Asian ethnicity is a favorable prognostic factor for overall survival in non-small cell lung cancer (NSCLC) and is independent of smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Sep; 4(9):1083-93. PubMed ID: 19652625
[TBL] [Abstract][Full Text] [Related]
4. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
5. A comparison study of clinicopathologic characteristics of Southern California Asian American Non-small Cell Lung Cancer (NSCLC) patients by smoking status.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Feb; 5(2):158-68. PubMed ID: 20040896
[TBL] [Abstract][Full Text] [Related]
6. Association between race and survival of patients with non--small-cell lung cancer in the United States veterans affairs population.
Ganti AK; Subbiah SP; Kessinger A; Gonsalves WI; Silberstein PT; Loberiza FR
Clin Lung Cancer; 2014 Mar; 15(2):152-8. PubMed ID: 24361249
[TBL] [Abstract][Full Text] [Related]
7. Gender, histology, and time of diagnosis are important factors for prognosis: analysis of 1499 never-smokers with advanced non-small cell lung cancer in Japan.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Kawahara M; Maruyama Y
J Thorac Oncol; 2010 Jul; 5(7):1011-7. PubMed ID: 20502360
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
9. How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in California? Explaining the Hispanic paradox.
Patel MI; Schupp CW; Gomez SL; Chang ET; Wakelee HA
J Clin Oncol; 2013 Oct; 31(28):3572-8. PubMed ID: 23960183
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors for survival of stage I nonsmall cell lung cancer patients : a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2007 Oct; 110(7):1532-41. PubMed ID: 17702091
[TBL] [Abstract][Full Text] [Related]
11. Histology and smoking status predict survival of patients with advanced non-small-cell lung cancer. Results of West Japan Oncology Group (WJOG) Study 3906L.
Kogure Y; Ando M; Saka H; Chiba Y; Yamamoto N; Asami K; Hirashima T; Seto T; Nagase S; Otsuka K; Yanagihara K; Takeda K; Okamoto I; Aoki T; Takayama K; Yamasaki M; Kudoh S; Katakami N; Miyazaki M; Nakagawa K
J Thorac Oncol; 2013 Jun; 8(6):753-8. PubMed ID: 23575412
[TBL] [Abstract][Full Text] [Related]
12. Should patients with stage IB non-small cell lung cancer receive adjuvant chemotherapy? A comparison of survival between the 8th and 7th editions of the AJCC TNM staging system for stage IB patients.
Wang J; Wu N; Lv C; Yan S; Yang Y
J Cancer Res Clin Oncol; 2019 Feb; 145(2):463-469. PubMed ID: 30474757
[TBL] [Abstract][Full Text] [Related]
13. Disparate outcomes in nonsmall cell lung cancer by immigration status.
Chau B; Ituarte PH; Shinde A; Li R; Vazquez J; Glaser S; Massarelli E; Salgia R; Erhunmwunsee L; Ashing K; Amini A
Cancer Med; 2021 Apr; 10(8):2660-2667. PubMed ID: 33734614
[TBL] [Abstract][Full Text] [Related]
14. Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system.
Arslan D; Bozcuk H; Gunduz S; Tural D; Tattli AM; Uysal M; Goksu SS; Bassorgun Cİ; Koral L; Coskun HS; Ozdogan M; Savas B
Asian Pac J Cancer Prev; 2014; 15(6):2465-72. PubMed ID: 24761848
[TBL] [Abstract][Full Text] [Related]
15. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
Ou SH; Zell JA; Ziogas A; Anton-Culver H
Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
[TBL] [Abstract][Full Text] [Related]
16. Primary signet-ring carcinoma (SRC) of the lung: a population-based epidemiologic study of 262 cases with comparison to adenocarcinoma of the lung.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2010 Apr; 5(4):420-7. PubMed ID: 20130484
[TBL] [Abstract][Full Text] [Related]
17. Ethnic differences in survival outcome in patients with advanced stage non-small cell lung cancer: results of a meta-analysis of randomized controlled trials.
Soo RA; Loh M; Mok TS; Ou SH; Cho BC; Yeo WL; Tenen DG; Soong R
J Thorac Oncol; 2011 Jun; 6(6):1030-8. PubMed ID: 21532500
[TBL] [Abstract][Full Text] [Related]
18. Impact of Asian ethnicity on outcome in metastatic EGFR-mutant non-small cell lung cancer.
Gibson AJW; D'Silva A; Elegbede AA; Tudor RA; Dean ML; Bebb DG; Hao D
Asia Pac J Clin Oncol; 2019 Dec; 15(6):343-352. PubMed ID: 31486229
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Elderly Patients Who Receive Combined Modality Therapy for Locally Advanced Non-Small-Cell Lung Cancer.
Zaki M; Dominello M; Dyson G; Gadgeel S; Wozniak A; Miller S; Paximadis P
Clin Lung Cancer; 2017 Jan; 18(1):e21-e26. PubMed ID: 27567356
[TBL] [Abstract][Full Text] [Related]
20. Effect of smoking on survival from non-small cell lung cancer: a retrospective Veterans' Affairs Central Cancer Registry (VACCR) cohort analysis.
Bhatt VR; Batra R; Silberstein PT; Loberiza FR; Ganti AK
Med Oncol; 2015 Jan; 32(1):339. PubMed ID: 25429831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
